Consensus GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:04 2024-05-31 am EDT			5-day change	1st Jan Change
1,766 ^GBX	+2.11%		-0.45%	+21.81%

May. 31	US FDA approves Moderna's RSV vaccine, its second marketed product	RE
May. 30	Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	MT

Evolution of the average Target Price on GSK plc

Price target over the last 5 years

History of analyst recommendation changes

f394d2b87e04b0f6212944250f.WSy3Myi_r3dUj6N9cihuTKye7AxLdjmWlEiRVx3w43s.b2XVXHD0-0Ub2JcuG1gsK8X2vDk9A1XcxB7zL1mKlEwKavEAf_77GAG65g~dcebbe62660f5d8ef5000a74a248f89e

Analyst Recommendations on GSK plc

Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	May. 30	MT
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	May. 30	MT
Jefferies and UBS cut Anglo American	May. 30	AN
GSK : Upgraded to Neutral by Goldman Sachs	May. 30	ZD
GSK executive buys GBP20,026 worth shares	May. 20	AN
GSK: FOLLOWING SETTLEMENT OF PLACING, GSK WILL HAVE FULLY EXITED…	May. 17	RE
LBBW Raises GSK PT, Reiterates Buy Rating	May. 14	MT
DB and Berenberg raise Diploma price target	May. 14	AN
Jefferies Keeps GSK at Buy, Lifts PT	May. 13	MT
GSK : Deutsche Bank maintains a Buy rating	May. 13	ZD
GSK : Receives a Buy rating from Jefferies	May. 13	ZD
BAE Systems and Mondi cut to 'neutral'	May. 13	AN
GSK : Receives a Buy rating from Bernstein	May. 08	ZD
Bernstein Lifts GSK PT, Keeps Outperform Rating	May. 08	MT
UBS raises Centrica to 'buy' from 'neutral	May. 08	AN
GSK: CITIGROUP RAISES TARGET PRICE TO 2120P FROM 2100P…	May. 08	RE
DZ Bank Keeps GSK at Hold, Raises PT	May. 07	MT
AstraZeneca target raised; Antofagasta lowered	May. 07	AN
GSK : UBS remains its Buy rating	May. 06	ZD
GSK : DZ Bank remains Neutral	May. 03	ZD
GSK : Buy rating from Deutsche Bank	May. 02	ZD
GSK : UBS keeps its Buy rating	May. 02	ZD
GSK : UBS reiterates its recommendation on the share	May. 02	CF
Deutsche Bank likes TP ICAP but says sell CMC	May. 02	AN
GSK : JP Morgan reaffirms its Sell rating	May. 02	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.66 GBP

Average target price

20.26 GBP

Spread / Average Target

+14.69%

High Price Target

34.79 GBP

Spread / Highest target

+96.93%

Low Price Target

12 GBP

Spread / Lowest Target

-32.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GSK plc

Goldman Sachs
LBBW
Jefferies & Co.
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JEFFERIES	Peter Welford
Bernstein
BERNSTEIN RESEARCH	Justin Smith
DZ BANK	Elmar Kraus
UBS
alphavalue	Abhishek Raval
JPMORGAN	James Gordon
Barclays
BERENBERG	Kerry Holford
Guggenheim
Citigroup
Deutsche Bank Securities
Morgan Stanley
Berenberg Bank
CREDIT SUISSE	Dominic Lunn
HSBC
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK	Emmanuel Papadakis
KEPLER CHEUVREUX	David Evans
BAADER BANK
SVB Leerink
BANK OF AMERICA (BOFA)	Graham Parry

Ratings for GSK plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar